carbostyril has been researched along with Epithelial Ovarian Cancer in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fujiwara, K; Hasegawa, K; Ikeda, Y; Imai, Y; Iwasa, A; Kato, T; Miyamoto, T; Nakamura, Y; Okabe, S; Park, JH; Takamatsu, N | 1 |
1 other study(ies) available for carbostyril and Epithelial Ovarian Cancer
Article | Year |
---|---|
T-LAK Cell-Originated Protein Kinase (TOPK) as a Prognostic Factor and a Potential Therapeutic Target in Ovarian Cancer.
Topics: Animals; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Disease-Free Survival; Female; Forkhead Box Protein M1; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Mitogen-Activated Protein Kinase Kinases; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Prognosis; Protein Kinase Inhibitors; Quinolones; Thiophenes | 2016 |